Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 16, 2025 16:05 ET | Source: TheRas, Inc. (d/b/a BBOT)

BBOT to Present at the 44th Annual J.P. Morgan Healthcare Conference

BBOT today announced that members of its leadership team will participate in a presentation at the 44th Annual J.P. Morgan Healthcare Conference.
December 16, 2025 12:18 ET | Source: Equity Insider

Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The FDA is moving to require just one clinical trial for new drug approvals, signaling a dramatic...
December 16, 2025 12:00 ET | Source: USA News Group

From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Stanford researchers achieved complete diabetes reversal in mice using a combined blood stem cell and...
December 16, 2025 08:40 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer

Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speed Application follows recent successful toxicology studies,...
December 16, 2025 07:30 ET | Source: Vertero Therapeutics, Inc.

Vertero Strengthens Board of Directors with Appointment of Independent Chair R. Scott Greer

Vertero strengthens Board of Directors with Independent Chair R. Scott Greer, life sciences veteran, experienced executive, investor, and advisor.
December 16, 2025 06:30 ET | Source: Beacon Biosignals

Beacon Biosignals Announces Partnership with Harmony Biosciences to Advance Objective Clinical Endpoints in Hypersomnia Conditions Through Quantitative EEG

Beacon Biosignals partners with Harmony Biosciences to quantitatively measure excessive daytime sleepiness in phase 3 clinical trial.
December 16, 2025 06:00 ET | Source: Culture Biosciences

Culture Biosciences Announces Close of Series C Round to Accelerate Commercial Growth of Stratyx 250 and Console Platform

Culture Biosciences closed a Series C to scale Stratyx™ 250 and advance its AI-powered Console platform for biologics, cell therapy, and synthetic biology.
December 15, 2025 16:08 ET | Source: Abivax

Abivax Presents Third Quarter 2025 Financial Results

Abivax Presents Third Quarter 2025 Financial Results Cash and cash equivalents of EUR 589.7 (as of September 30, 2025) with a cash runway into Q4 2027 PARIS, France, December 15, 2025, 10:05 p.m....
December 15, 2025 16:05 ET | Source: Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

CONSHOHOCKEN, Pa., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) today announced that the company will participate in the J.P. Morgan Annual Healthcare Conference...
December 15, 2025 10:30 ET | Source: The Lundquist Institute for Biomedical Innovation

The Lundquist Institute and its start-up company Vitalex Biosciences Announces Strategic Advancement of Second-Generation fungal Vaccine VXV-01 through Phase 1 Trials under $40 Million Competitive Contract from NIH/NIAID

Los Angeles, CA, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The Lundquist Institute (TLI) and its start-up company Vitalex Biosciences (Vitalex) are pleased to announce that the second-generation fungal...